<soap:Envelope xmlns:soap="http://schemas.xmlsoap.org/soap/envelope/">
    <soap:Body>
        <ns2:getStudyDetailsResponse xmlns:ns2="http://services.ctep.nci.nih.gov/">
            <StudyDetails xmlns="">
                <ctcVersion>4.0</ctcVersion>
                <currentStatus>Complete</currentStatus>
                <currentStatusDate>1992-12-07</currentStatusDate>
                <localDocumentNumber>85-C-197</localDocumentNumber>
                <monitoringMethod>ADU</monitoringMethod>
                <nciDocumentNum>T85-0283</nciDocumentNum>
                <participationType>Clinical Center</participationType>
                <phase>I</phase>
                <primaryStudyType>Treatment</primaryStudyType>
                <sponsorOrganization></sponsorOrganization>
                <studyAgents>
                    <studyAgent createdDate="07-17-1999 16:02:36" lead="Yes" updatedDate="02-11-2003 17:58:19">
                        <agent>
                            <nscNumber>603062</nscNumber>
                            <agentName>Porfimer sodium (Photofrin)</agentName>
                            <agentStatus>Active</agentStatus>
                            <inds>
                                <ind lead="No">
                                    <indHolder>CTEP</indHolder>
                                    <indNumber>27637</indNumber>
                                </ind>
                            </inds>
                        </agent>
                        <commercialInvestigational>Investigational</commercialInvestigational>
                    </studyAgent>
                </studyAgents>
                <studyDevices/>
                <studyDiseases>
                    <studyDisease createdDate="07-17-1999 15:52:33" lead="Yes" updatedDate="12-29-2004 17:36:13">
                        <diseaseName>Solid tumor, NOS</diseaseName>
                        <reportingMedDRA>10029000</reportingMedDRA>
                    </studyDisease>
                </studyDiseases>
                <studyOrganizations>
                    <studyOrganization createdDate="12-18-1998 18:09:42" role="Document to Lead Organization"
                                       updatedDate="01-04-2001 17:16:05">
                        <localDocumentNumber>85-C-197</localDocumentNumber>
                        <organization>
                            <ctepId>NCIROB</ctepId>
                            <organizationName>National Cancer Institute Radiation Oncology Branch</organizationName>
                            <organizationType>CLC</organizationType>
                        </organization>
                        <status>Active</status>
                        <principalInvestigator ctepInvestigatorId="21836">
                            <firstname>Paul</firstname>
                            <middlename xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:nil="true"/>
                            <lastname>Okunieff</lastname>
                            <email/>
                            <principalInvestigatorStatus>Active</principalInvestigatorStatus>
                        </principalInvestigator>
                    </studyOrganization>
                </studyOrganizations>
                <studyTherapies>
                    <therapy createdDate="10-20-1999 12:59:26" updatedDate="">
                        <ctepName>Radiation Therapy</ctepName>
                        <medDRACode>10037770</medDRACode>
                        <preferredTerm>Radiation Therapy</preferredTerm>
                    </therapy>
                    <therapy createdDate="11-23-1999 11:42:43" updatedDate="">
                        <ctepName>Therapy (NOS)</ctepName>
                        <medDRACode>90003012</medDRACode>
                        <preferredTerm xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:nil="true"/>
                    </therapy>
                </studyTherapies>
                <studyTreatmentAssignments/>
                <title>Phase I study of photodynamic therapy with laser light and Photofrin II for surface
                    Malignancies
                </title>
            </StudyDetails>
        </ns2:getStudyDetailsResponse>
    </soap:Body>
</soap:Envelope>